Advertisement

Pharmacy

Purdue Pharma, the embattled OxyContin maker, laid off the remaining members of its sales force June 19, as it shifts its focus away from opioids and pursues cancer and central nervous disorder medications, according to the Stamford Advocate.

Advertisement

Pharmaceutical giant Roche Holding will pay $2.4 billion to acquire the remaining shares it doesn't already own of Foundation Medicine, putting more stake into a future for personalized cancer treatments, according to The Wall Street Journal.

PAM DELAGARDELLE. President and CEO of UnityPoint Health – Waterloo On the top challenge “The affordability of prescription drugs is one of the primary areas of focus at UnityPoint Health. Medications help keep many conditions, such as diabetes, hypertension thyroid…

Advertisement